Hopp til innhold

Valgte elementer er lagt i handlekurven

Gå til handlekurv

Artikkel

Vitenskapelige publikasjoner med data fra RAVN

Publisert Oppdatert



Har du funnet en feil?

Aktuelle publikasjoner om influensaresistens:

  • Hungnes O. Dudman SG. Resistance in influenza viruses. Tidsskrift for Den Norske Laegeforening. 128(22):2601-6, 2008.
  • Lackenby A., Hungnes O., Dudman S.G., Meijer A., Paget W.J., Hay A.J., Zambon M.C. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 2008;13(5).
  • Hauge SH. Dudman S. Borgen K. Lackenby A. Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerging Infectious Diseases. 15(2):155-62, 2009.  
  • Hauge SH. Blix HS. Borgen K. Hungnes O. Dudman SG. Aavitsland P. Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08. Virology Journal. 6:54, 2009.
  • Ciancio BC. Meerhoff TJ. Kramarz P. Bonmarin I. Borgen K. Boucher CA. Buchholz U. Buda S. Dijkstra F. Dudman S. Duwe S. Hauge SH. Hungnes O. Meijer A. Mossong J. Paget WJ. Phin N. van der Sande M. Schweiger B. Nicoll A. Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. 14(46), 2009.
  • Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Meijer A. Lackenby A. Hungnes O. Lina B. van-der-Werf S. Schweiger B. Opp M. Paget J. van-de-Kassteele J. Hay A. Zambon M. European Influenza Surveillance Scheme. Emerging Infectious Diseases. 15(4):552-60, 2009 Apr.

Publikasjoner om hiv-resistens

  • Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. Wensing AM, van de Vijver DA, Angarano G, Asjö B  et al., J Infect Dis. 2005 192:958-66. Erratum in: J Infect Dis. 2005 Oct 15;192(8):1501.
  • HIV-1-resistens mot antiretrovirale midler. Åsjø B, Ulvestad E. Tidsskr. Nor Legeforen. 2001; 121:3421-4
  • Medikamentell resistens vid HIV-infektion. Åsjø B, Langeland N. Tidsskr Nor Laegeforen. 2008;128:2593-6.
  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update. Bennett DE et al. PloS ONE 2009;4(3): e4724.
  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel. Hirsch MS et al. CID 2008:47;266-85.

Publikasjoner om HBV/HCV-resistens

  • Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.Lok AS, Zoulim F, Locarnini S et al. Hepatology 2007; 46: 254–65. 
  • Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy. Le Guillou-Guillemette H, Vallet S, Gaudy-Graffin C et al. World J Gastroenterology 2007; 13: 2416–26.

Publikasjoner om CMV/HSV-resistens

  • Cytomegalovirus Resistance in Solid Organ Transplant Recipients Treated with Intravenous Ganciclovir or Oral Valganciclovir. Boivin G, Goyette N, Rollag H , Jardine AG5, Pescovitz MD, Åsberg A, Hartmann A, Humar A. Antiviral Therapy 14:697-704,2009.
  • Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Clin Microbiol Rev.16(1):114-28, 2003.